H.R.6190 - Asthma Inhalers Relief Act of 2012112th Congress (2011-2012)
|Sponsor:||Rep. Burgess, Michael C. [R-TX-26] (Introduced 07/25/2012)|
|Committees:||House - Energy and Commerce|
|Committee Reports:||H. Rept. 112-673|
|Latest Action:||House - 12/12/2012 On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623). (All Actions)|
|Roll Call Votes:||There has been 1 roll call vote|
This bill has the status Failed House
Here are the steps for Status of Legislation:
- Failed House
Summary: H.R.6190 — 112th Congress (2011-2012)All Information (Except Text)
Reported to House without amendment (09/14/2012)
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.
Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.
Terminates this Act on August 1, 2013.